Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Infective endocarditis and perivalvular abscess: a dangerous duo

Stephen D. Shafran
CMAJ July 09, 2002 167 (1) 38-39;
Stephen D. Shafran
Dr. Shafran is Professor of Medicine, Division of Infectious Diseases, University of Alberta, Edmonton, Alta.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Infective endocarditis involving the left side of the heart remains a serious medical problem, with substantial morbidity and mortality. Its incidence has been reported to range from 1.7 cases1 to 6.2 cases2 per 100 000 person-years, the risk increasing significantly with advancing age. In most series, more men than women are affected, but not all studies have shown a male preponderance. The risk of infective endocarditis among injection drug users is considerably higher, but most cases are confined to the tricuspid valve and are associated with a very low death rate. With the declining incidence of rheumatic heart disease in most developed countries, an increasing proportion of cases of infective endocarditis occur in people with no known underlying heart disease, those with bicuspid aortic valves and those with mitral valve prolapse.

Serious complications and deaths related to left-sided infective endocarditis are due to either cerebral emboli causing severe neurologic deficits or to intracardiac suppurative complications, which can cause severe valvular regurgitation, rupture of the ventricular septum, rupture of the ventricular free wall and disruption of the conducting system, with attendant heart block.

The clinical diagnosis of infective endocarditis has been greatly improved by the advent and subsequent improvements in echocardiography. In recognition of this, revised criteria for the clinical diagnosis were introduced in 1994 by the Duke Endocarditis Service,3 now widely known as the “Duke criteria.” Many investigators have shown that these criteria are superior to previously used clinical criteria. Nevertheless, a few deficiencies in the Duke criteria have been identified, leading to recent modifications.4

Perivalvular abscess is a known and feared complication of left-sided endocarditis because it is associated with increased mortality. It appears to occur more often with prosthetic valve endocarditis than with native valve endocarditis, and it appears to be more common when the pathogen is Staphylococcus aureus than when viridans group streptococci are the infecting organisms. The first use of echocardiography to detect a perivalvular abscess before surgery was reported as long ago as 1978.5 However, the advent of transesophageal echocardiography has markedly improved the diagnostic sensitivity of echocardiography for infective endocarditis in general and perivalvular abscess in particular.6 In the largest series of perivalvular abscesses reported, the sensitivity of transesophageal echocardiography for detecting perivalvular abscess was 80%, as compared with only 36% for transthoracic echocardiography.7

In this issue (see page19) Kwan-Leung Chan reports on 43 consecutive patients with perivalvular abscess treated at the University of Ottawa Heart Institute.8 There was a male preponderance, and 60% of the patients had prosthetic valve endocarditis. All cases involved the left side of the heart, with the aortic valve being involved in 36 cases, the mitral valve in only 3 cases and both valves in 4 cases. Consistent with previous reports, S. aureus was the most common pathogen.

Chan does not indicate the total number of cases of endocarditis assessed by the University of Ottawa Heart Institute during the study period, what proportion involved native valves versus prosthetic valves, what proportions were due to which pathogens and, perhaps most important, what proportion was referred to this regional referral centre specifically for consideration of cardiac surgery, which is not available elsewhere in the Ottawa region. These factors may have significantly affected the data, as referral bias is well known to influence the clinical features of cases of infective endocarditis.9 The incidence of perivalvular abscess has varied substantially in the literature, from 13% of cases in one clinical series10 to 30% in an autopsy study,11 which will obviously overestimate the incidence of this serious complication.

Nevertheless, Chan importantly points out the serious morbidity and mortality associated with the complication of perivalvular abscess. Cardiac surgery was performed in nearly all subjects, except those who had contraindications or who were considered to be at exceedingly high surgical risk. Slightly over half of the patients had died after a mean of 4.5 years of follow-up, mostly of cardiac causes. Echocardiography performed in 24 patients following cardiac surgery showed that a substantial minority had significant paraprosthetic regurgitation and pseudoaneurysms despite surgery. The functional status of these survivors was not described.

Left-sided infective endocarditis continues to be a serious disease, particularly when S. aureus is the pathogen or a prosthetic valve is involved. It carries substantial morbidity and mortality despite modern medical and surgical management. Although case series continue to suggest that the outcome is likely improved with surgery,10,12,13,14,15 these studies are not randomized and are consistently biased against medical therapy alone by excluding from the surgical group patients judged to be at very high surgical risk. Randomized trials of medical versus surgical therapy have never been conducted and are probably impossible to carry out.

In recognition of the limitations of the data, the current consensus is that intracardiac abscesses should be treated surgically as well as with bactericidal antibiotic therapy. Patients with infective endocarditis need to be monitored vigilantly for complications, and these should be treated as quickly as possible. Transesophageal echocardiography is a significant advance that makes the diagnosis of infective endocarditis easier and identifies intracardiac abscesses earlier, when intervention may prove more fruitful. Consequently, it is the preferred mode of echocardiography when infective endocarditis is suspected.

𝛃 See related article page 19

Footnotes

  • Competing interests: None declared.

References

  1. 1.↵
    Berlin JA, Abrutyn E, Strom BL, Kinman JL, Levison ME, Korzeniowski OM, et al. Incidence of infective endocarditis in the Delaware Valley, 1988–1990. Am J Cardiol 1995;76:933-6.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. Medicine 1995; 74:324-39.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96:200-9.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Mardelli TJ, Ogawa S, Hubbard FE, Dreifus LS, Meixell LL. Cross-sectional echocardiographic detection of aortic ring abscess in bacterial endocarditis. Chest 1978;74:576-8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Daniel WG, Mügge A, Martin RP, Lindert O, Hausmann D, Nonnast-Daniel B, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991;324:795-800.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Choussat R, Thomas D, Isnard R, Michel PL, Iung B, Hanania B, et al. Perivalvular abscesses associated with endocarditis: clinical features and prognostic factors of overall survival in a series of 233 cases. Eur Heart J 1999;20:232-41.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Chan KL. Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess. CMAJ 2002;166(1): 19-24. Available: www.cmaj.ca/cgi/content/full/167/1/19.
    OpenUrl
  9. 9.↵
    Steckelberg JM, Melton LJ, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990;88:582-8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Sandre R, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 1996;22:276-86.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Arnett EN, Roberts WC. Valve ring abscess in infective endocarditis: frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation 1976;54:140-5.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Nissen H, Nielsen PF, Frederiksen M, Helleberg C, Nielsen JS. Native valve infective endocarditis in the general population: a 10-year survey of the clinical picture during the 1980s. Eur Heart J 1992;12:872-7.
    OpenUrl
  13. 13.↵
    Yu VL, Fang GD, Keys TF, Harris AA, Gentry LO, Fuchs PC, et al. Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only. Ann Thorac Surg 1994;58:1073-7.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Jung JY, Saab SB, Almond CH. The case for early surgical treatment of left-sided primary infective endocarditis. A collective review. J Thorac Cardiovasc Surg 1975;70:509-18.
    OpenUrl
  15. 15.↵
    Bishara J, Leibovici L, Gartman-Israel D, Sage A, Kazakov A, Miroshnik E, et al. Long-term outcome of infective endocarditis: the impact of early surgical intervention. Clin Infect Dis 2001;33:1636-43.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

CMAJ
Vol. 167, Issue 1
9 Jul 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Infective endocarditis and perivalvular abscess: a dangerous duo
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Infective endocarditis and perivalvular abscess: a dangerous duo
Stephen D. Shafran
CMAJ Jul 2002, 167 (1) 38-39;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Infective endocarditis and perivalvular abscess: a dangerous duo
Stephen D. Shafran
CMAJ Jul 2002, 167 (1) 38-39;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antiracist practice for pediatric surgeons in Canada
  • Understanding and addressing Islamophobia through trauma-informed care
  • Dismantling gendered Islamophobia in medicine
Show more Commentary

Similar Articles

Collections

  • Topics
    • Cardiothoracic surgery
    • Cardiovascular medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire